A rigorous and impartial peer-review process is essential for publication, which can help authors revise their papers in a timely manner and contribute to a sound academic environment.
The Editorial Office of Rare Disease and Orphan Drugs Journal (RDODJ) is pleased to announce that the journal has been a member of the Committee on Publication Ethics (COPE).
Rare Diseases Foundation Annual Scientific Conference: COLLOQUE SCIENTIFIQUE ANNUEL 2022 was successfully held on May 31, 2022, in Paris, France. Rare Disease and Orphan Drugs Journal supported two Best Poster Awards of the conference.
To provide young scholars with an active academic exchange platform for exchanging ideas with each other and influential experts in rare disease and orphan drugs, the Editorial Office of Rare Disease and Orphan Drugs Journal (RDODJ) is constructing an editorial board specifically for young editorial members.
Today, OAE formally announced the appointment of Professor Daniel Scherman, as the Editor-in-Chief of Rare Disease and Orphan Drugs Journal (RDODJ), a new online journal launched by OAE in March 2021.
Rare Disease and Orphan Drugs Journal
